Did you know that most breast cancer tumors are known as estrogen and progesterone-positive? This means the hormones literally “feed” these tumors to grow bigger and more aggressive.
And did you know that a significant percentage of those hormone-positive cancers are caused by combined hormone replacement therapy?
Based on revelations such as these, a Reno, Nevada jury last month award $134 million in compensatory and punitive damages to three Nevada women whose breast cancers were found to be caused by the combined hormone therapy products manufactured by the drug giant Wyeth.
The jury awarded $34 million in compensatory damages for Arlene Rowatt, 67 of Incline Village, NV. Jeraldine Scofield, 75 of Fallon, NV, and Pamela Forrester, 64 of Yerington, NV. It later added $99 million in punitive damages, resulting in the largest personal injury judgment in the history of Nevada, and the largest judgment against Wyeth in a long string of hormone replacement cases.
All three women began taking the Wyeth drug Premarin, as well as a related drug Progestin, over ten years ago. They later switched to Prempro, a Wyeth product that combined Premarin and Progesterone in the same pill. They stopped taking the drugs once their breast cancers were diagnosed.
More than 5,500 cases involving hormone replacement drugs and cancer victims are pending throughout the nation.
The Reno jury found that Wyeth provided inadequate warnings about the drugs’ breast cancer risk and that the drugs they took for years were the cause of their breast cancer. The jury also found Wyeth guilty of fraudulently concealing their drug’s dangers.